Triamcinolone aminobenzal benzamidoisobutyrate

Today, Triamcinolone aminobenzal benzamidoisobutyrate is a topic of great relevance and interest to a wide spectrum of the public. With the advancement of technology and globalization, Triamcinolone aminobenzal benzamidoisobutyrate has become an increasingly present topic in our lives, whether on a personal, professional or social level. Opinions on Triamcinolone aminobenzal benzamidoisobutyrate are varied and debated, making its study and understanding essential to understanding the world we live in. In this article, we will explore different perspectives on Triamcinolone aminobenzal benzamidoisobutyrate, analyzing its impact, evolution and relevance in different contexts.

Triamcinolone aminobenzal benzamidoisobutyrate
Clinical data
Trade namesTaucorten
Other namesTBI-PAB; TBI/PAB; Tbi-Pab; 16α,17α-(4-Dimethylamino-
benzyliden)triamcinolone 21-(β-benzoylamino)isobutyrate; 21-(3-(benzoylamino)-2-methyl-1-oxopropoxy)-16α,17α-(((4-(dimethylamino)phenyl)-
methylene)bis(oxy))-9α-fluoro-11β-hydroxypregna-1,4-diene-3,20-dione
Drug classCorticosteroid; Glucocorticoid
Identifiers
  • 2-{(4aS,6aS,6bS,10aS,10bS)-8--4b-fluoro-5-hydroxy-4a,6a-dimethyl-2-oxo-2,4a,4b,5,6,6a,9a,10,10a,10b,11,12-dodecahydro-6bH-naphthoindenodioxol-6b-yl}-2-oxoethyl 3-(benzoylamino)-2-methylpropanoate
CAS Number
PubChem CID
ChemSpider
UNII
Chemical and physical data
FormulaC41H47FN2O8
Molar mass714.831 g·mol−1
3D model (JSmol)
  • CC(CNC(=O)C1=CC=CC=C1)C(=O)OCC(=O)23C(C42(CC(C5(4CCC6=CC(=O)C=C65C)F)O)C)OC(O3)C7=CC=C(C=C7)N(C)C
  • InChI=1S/C41H47FN2O8/c1-24(22-43-35(48)25-9-7-6-8-10-25)36(49)50-23-33(47)41-34(51-37(52-41)26-11-14-28(15-12-26)44(4)5)20-31-30-16-13-27-19-29(45)17-18-38(27,2)40(30,42)32(46)21-39(31,41)3/h6-12,14-15,17-19,24,30-32,34,37,46H,13,16,20-23H2,1-5H3,(H,43,48)/t24?,30-,31-,32?,34?,37?,38-,39-,40?,41+/m0/s1
  • Key:NHLSSOMFJSWGTD-VYWRQCFVSA-N

Triamcinolone aminobenzal benzamidoisobutyrate (TBI-PAB; brand name Taucorten) is a synthetic glucocorticoid corticosteroid which is no longer marketed.

References

  1. ^ Elks J (14 November 2014). The Dictionary of Drugs: Chemical Data: Chemical Data, Structures and Bibliographies. Springer. pp. 1228–. ISBN 978-1-4757-2085-3.
  2. ^ Martindale W, Royal Pharmaceutical Society of Great Britain. Dept. of Pharmaceutical Sciences (1993). The Extra Pharmacopoeia. Pharmaceutical Press. p. 740. ISBN 978-0-85369-300-0.